Stay updated on Daratumumab Retreatment in Relapsed Multiple Myeloma: Clinical Trial
Sign up to get notified when there's something new on the Daratumumab Retreatment in Relapsed Multiple Myeloma: Clinical Trial page.

Latest updates to the Daratumumab Retreatment in Relapsed Multiple Myeloma: Clinical Trial page
- Check7 days agoChange DetectedThe history adds a note that recruitment is closed (No longer looking for participants) and records a new version (v3.6.0); the older revision (v3.5.5) is removed from the history.SummaryDifference0.3%

- Check14 days agoChange DetectedThe page history now displays Revision: v3.5.5, replacing Revision: v3.5.4. This change reflects a background site update rather than any modification to the study data or record content.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe Record History now shows Revision: v3.5.4. This replaces the previous v3.5.3 entry and indicates an update to the platform revision label in the history list.SummaryDifference0.1%

- Check57 days agoChange DetectedThe page’s interface revision indicator was updated from v3.5.2 to v3.5.3, reflecting a platform/UI release without changing the underlying trial history content.SummaryDifference0.1%

- Check64 days agoChange DetectedA new Revision: v3.5.2 was added and Revision: v3.5.0 was removed.SummaryDifference0.1%

- Check93 days agoChange DetectedAdded revision v3.5.0 and deleted revision v3.4.3 in the Record History section.SummaryDifference0.1%

Stay in the know with updates to Daratumumab Retreatment in Relapsed Multiple Myeloma: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Daratumumab Retreatment in Relapsed Multiple Myeloma: Clinical Trial page.